| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,467 |
2,931 |
$166K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,049 |
1,749 |
$63K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
724 |
633 |
$58K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,783 |
1,594 |
$40K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
534 |
463 |
$26K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,330 |
1,179 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,452 |
1,308 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,519 |
1,179 |
$10K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
215 |
184 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
127 |
110 |
$4K |
| 87428 |
|
47 |
41 |
$2K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
18 |
15 |
$672.00 |
| 87634 |
|
13 |
13 |
$638.82 |
| 87807 |
|
38 |
35 |
$385.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
495 |
395 |
$347.92 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
539 |
427 |
$233.58 |
| 36415 |
Collection of venous blood by venipuncture |
57 |
52 |
$67.20 |
| 94760 |
|
150 |
129 |
$49.21 |
| 99000 |
|
342 |
319 |
$0.00 |
| 99080 |
|
1,272 |
1,200 |
$0.00 |
| 99051 |
|
13 |
13 |
$0.00 |